
Join to view full profile
7502 Greenville AveDallas, TX 75231
Dr. Mawla is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Neghae Mawla is a nephrologist with subspecialty in interventional nephrology, based in Dallas, TX. He completed his medical education at McGovern Medical School at UTHealth, followed by a residency in Internal Medicine and a fellowship in Nephrology at SSM Health/Saint Louis University School of Medicine. His areas of expertise include interventional nephrology, dialysis and vascular access placement, and fistula maturation. Dr. Mawla has contributed to the field through publications on ultrasound-guided percutaneous arteriovenous fistula creation and the complications of hemodialysis access. He has participated in clinical trials and received recognitions such as Fellow ASDIN and CMS Meaningful Use certifications.
Education & Training
SSM Health/Saint Louis University School of MedicineFellowship, Nephrology, 2004 - 2006
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2001 - 2004
McGovern Medical School at UTHealthClass of 2001
Certifications & Licensure
CA State Medical License 2025 - 2027
NC State Medical License 2025 - 2027
TX State Medical License 2006 - 2027
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Fellow ASDIN American Society of Diagnostic and Interventional Nephrology, 2018
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2012, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD Start of enrollment: 2015 Feb 10
- The Merit WRAPSODY AV Access Efficacy Study (WAVE) Start of enrollment: 2021 Mar 09
Publications & Presentations
PubMed
- 12 citationsLong-Term Results from the Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access.Jeffrey E Hull, William C Jennings, Randy I Cooper, Rajeev Narayan, Neghae Mawla
Journal of Vascular and Interventional Radiology. 2022-10-01 - 21 citationsFormation of downhill esophageal varices as a rare but serious complication of hemodialysis access: a case report and comprehensive literature review.Fadi A. Hussein, Neghae Mawla, Alex S. Befeler, Kevin J. Martin, Krista L. Lentine
Clinical and Experimental Nephrology. 2008-04-10
Press Mentions
Venova Medical Receives FDA IDE Approval for the VENOS-3 Pivotal Study of the Velocity™ Percutaneous AVF SystemAugust 21st, 2025
Venova’s Velocity pAVF System Pivotal Study Receives IDE ApprovalAugust 21st, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: